Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Neuroendocrine tumour (NET), Secondary cancers
Closed
Phase 3
This trial is looking at the order of treatment for people with neuroendocrine tumours of the pancreas (pNETs).
It is for people who have a NET that has spread elsewhere in the body and that cannot be removed with surgery. This is advanced or metastatic cancer.
Recruitment start: 9 December 2005
Recruitment end: 16 April 2019
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Nicholas Simon Reed
Grupo Español de Tumores Neuroendocrinos (GENTE)
Novartis Pharmaceuticals UK
Kantar Health
Last reviewed: 20 July 2020
CRUK internal database number: 15508